2',5'-dideoxyadenosine has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayukawa, K; Murata, J; Ogasawara, M; Saiki, I; Watanabe, H | 1 |
Abdel-Malek, ZA; Nordlund, JJ; Swope, VB; Trinkle, LS | 1 |
2 other study(ies) available for 2',5'-dideoxyadenosine and B16 Melanoma
Article | Year |
---|---|
Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone.
Topics: Adenylyl Cyclase Inhibitors; alpha-MSH; Animals; Biological Factors; Cell Movement; Colforsin; Culture Media, Conditioned; Cyclic AMP; Cycloheximide; Depression, Chemical; Dideoxyadenosine; Melanoma, Experimental; Mice; Neoplasm Proteins; Protein Denaturation; Protein Synthesis Inhibitors; Second Messenger Systems; Tumor Cells, Cultured | 1999 |
Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Bucladesine; Catechol Oxidase; Cyclic AMP; Dideoxyadenosine; Dideoxynucleosides; Dinoprostone; Interphase; Melanocyte-Stimulating Hormones; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Tumor Cells, Cultured | 1989 |